Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Baxter
Farmers Insurance
US Department of Justice
Julphar
Accenture

Generated: September 23, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,550,780

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,550,780 protect, and when does it expire?

Patent 9,550,780 protects AUSTEDO and is included in one NDA.

This patent has fourteen patent family members in ten countries.

Summary for Patent: 9,550,780
Title:Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
Abstract: The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (VMAT2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.
Inventor(s): Sommer; Andreas (Carlsbad, CA), Zhang; Chengzhi (San Diego, CA), Carter; John (Vista, CA), Arthur; John (Vista, CA), Bradbury; Margaret (Vista, CA), Gant; Thomas (Carlsbad, CA), Shahbaz; Manouchehr (San Diego, CA)
Assignee: Auspex Pharmaceuticals, Inc. (LaJolla, CA)
Application Number:15/071,797
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 9,550,780

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Teva Branded Pharm AUSTEDO deutetrabenazine TABLET;ORAL 208082-001 Apr 3, 2017 RX Yes No ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF TARDIVE DYSKINESIA ➤ Sign Up
Teva Branded Pharm AUSTEDO deutetrabenazine TABLET;ORAL 208082-001 Apr 3, 2017 RX Yes No ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF A NEURODEGENERATIVE DISEASE OR A SYMPTOM THEREOF ➤ Sign Up
Teva Branded Pharm AUSTEDO deutetrabenazine TABLET;ORAL 208082-002 Apr 3, 2017 RX Yes No ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF A NEURODEGENERATIVE DISEASE OR A SYMPTOM THEREOF ➤ Sign Up
Teva Branded Pharm AUSTEDO deutetrabenazine TABLET;ORAL 208082-002 Apr 3, 2017 RX Yes No ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF TARDIVE DYSKINESIA ➤ Sign Up
Teva Branded Pharm AUSTEDO deutetrabenazine TABLET;ORAL 208082-003 Apr 3, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF A NEURODEGENERATIVE DISEASE OR A SYMPTOM THEREOF ➤ Sign Up
Teva Branded Pharm AUSTEDO deutetrabenazine TABLET;ORAL 208082-003 Apr 3, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF TARDIVE DYSKINESIA ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,550,780

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013318182 ➤ Sign Up
Australia 2018222896 ➤ Sign Up
Brazil 112015005894 ➤ Sign Up
Canada 2883641 ➤ Sign Up
China 104684555 ➤ Sign Up
European Patent Office 2897615 ➤ Sign Up
Hong Kong 1212232 ➤ Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
QuintilesIMS
Julphar
Cipla
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.